Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
RecruitingPhase 4NCT05347069
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.
Study details
- Official title
- Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
- Conditions
- Stable Angina Pectoris
- Coronary Artery Disease
- Ischemic Heart Disease
- Interventions
- Drug: Aspirin
- Drug: No aspirin
- Sponsor
- Takeshi Morimoto
- Organization
- Kyoto University, Graduate School of Medicine
- Start date
- 2022-06-14
- Primary completion
- 2030-03
- Sex
- All
- Age range
- from 20 Years
- Results posted
- No results posted in this snapshot
- Countries
- Japan
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with chronic coronary syndromes with ≧50% diameter stenosis in one or more major coronary vessels/major branches on coronary CT or coronary angiography but not eligible for coronary revascularization * Patients for whom consent can be obtained Exclusion Criteria: * Patients with history of acute coronary syndromes (ACS) * Patients with history of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) * Patients with left main trunk stenosis (≥50%) * Patients for whom aspirin administration is mandatory * Patients undergoing antithrombotic therapy other than aspirin * Patients with atrial fibrillation * Patients with history of stroke within six months * Patients scheduled for major surgical procedures that will require aspirin discontinuation * Patients with contraindication of aspirin * Patients expected to have a prognosis of 1 year or less due to comorbidities * Women of child-bearing potential or women who have a positive pregnancy test at enrolment or randomization * Patients who are judged by attending physicians to be inappropriate to participate in this study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05347069